Kingwaytek Technology Co., Ltd. (TPEX:6516)

Ligand Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	134.74	113.74	210	229.35	93.72	181.91
Short-Term Investments	739.42	763.93	754.23	662.45	747.16	602.88
Cash & Short-Term Investments	874.17	877.67	964.23	891.8	840.88	784.79
Cash Growth	-7.76%	-8.98%	8.12%	6.05%	7.15%	3.92%
Accounts Receivable	48.21	67.51	82.33	117.86	108.86	142.38
Other Receivables	49.49	23.4	39.59	2.46	0.04	4.11
Receivables	97.7	90.91	121.92	120.32	108.9	146.49
Inventory	-	14.76	0.06	0.12	0.01	0.02
Prepaid Expenses	-	11.98	16.63	18.85	11.29	5.14
Other Current Assets	28.67	8.65	2.25	0.01	12.67	22.36
Total Current Assets	1,001	1,004	1,105	1,031	973.74	958.8
Property, Plant & Equipment	47.7	49.22	76.51	97.96	58.35	56.61
Long-Term Investments	212.58	210.88	53.22	55.53	69.59	46.64
Other Intangible Assets	0.28	0.25	0.59	0.83	1.67	2.87
Long-Term Accounts Receivable	4.43	5.16	-	3.54	-	1.88
Long-Term Deferred Tax Assets	0.07	0.07	0.06	0.79	2.14	1.51
Long-Term Deferred Charges	12.03	11.62	6.98	3.61	-	-
Other Long-Term Assets	16.59	15.92	24.15	21.8	20.01	45.88
Total Assets	1,294	1,297	1,267	1,215	1,125	1,114
Accounts Payable	39.67	29.01	80.97	30.17	27	40.64
Accrued Expenses	13.9	40.12	35.56	24.35	18.77	16.38
Current Portion of Leases	8.75	10.94	11.98	11.68	14.69	15.09
Current Income Taxes Payable	10.73	6.88	11.27	14.78	-	-
Current Unearned Revenue	56.27	67.29	41.79	44.84	27.29	23.98
Other Current Liabilities	6.37	6.96	6.63	8.36	7.44	20.38
Total Current Liabilities	135.69	161.2	188.2	134.19	95.2	116.47
Long-Term Leases	2.51	0.28	11.22	21.33	0.36	14.81
Long-Term Unearned Revenue	38.28	39.75	38.45	30.1	28.78	26.96
Long-Term Deferred Tax Liabilities	5.18	4.6	1.52	2.45	4.74	0.15
Other Long-Term Liabilities	-	-	0	0	0.02	0.23
Total Liabilities	181.67	205.83	239.39	188.06	129.09	158.61
Common Stock	563.37	563.37	512.47	466.2	424.14	385.9
Additional Paid-In Capital	404.98	404.98	453.03	496.99	534.84	573.08
Retained Earnings	152.15	131.75	115.49	114.23	76.53	35.46
Treasury Stock	-	-	-38.85	-38.85	-38.85	-38.85
Comprehensive Income & Other	-7.95	-8.82	-14.96	-11.51	-0.26	-
Shareholders' Equity	1,113	1,091	1,027	1,027	996.41	955.6
Total Liabilities & Equity	1,294	1,297	1,267	1,215	1,125	1,114
Total Debt	11.27	11.22	23.2	33.02	15.06	29.9
Net Cash (Debt)	862.9	866.45	941.03	858.78	825.83	754.89
Net Cash Growth	-6.94%	-7.92%	9.58%	3.99%	9.40%	4.70%
Net Cash Per Share	15.34	15.43	16.79	15.31	14.74	13.47
Filing Date Shares Outstanding	56.34	56.34	55.99	55.99	55.99	55.99
Total Common Shares Outstanding	56.34	56.34	55.99	55.99	55.99	55.99
Working Capital	864.85	842.77	916.88	896.9	878.55	842.33
Book Value Per Share	19.75	19.37	18.35	18.34	17.80	17.07
Tangible Book Value	1,112	1,091	1,027	1,026	994.73	952.73
Tangible Book Value Per Share	19.74	19.37	18.34	18.33	17.77	17.02
Machinery	72.94	73.17	65.25	65.09	70.89	78.98
Leasehold Improvements	10.58	10.1	10.1	10.14	4.44	26.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.